Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04974580 · ClinicalTrials.gov registry record · Phase 4
Research and Innovation to Stop E-cigarette/Vaping in Young Adults
A Phase 4 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 508
- Enrollment target
NCT04974580 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 508 participants.
The verdict
NCT04974580, a Phase 4 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 508 participants
- Enrollment target
Study Summary
The aim of this study is to test intervention components to help young adults quit vaping. A 2x2 factorial design will be used where all participants receive quitline-delivered behavioral phone counseling, and components to be tested are a digital intervention (with text and online cessation support) and nicotine replacement therapy (NRT). The research questions and hypotheses for this study are: 1. Which components and combinations of intervention yield the greatest success rates for exclusive vaping cessation among young adult exclusive e-cigarette users? H1: The complete condition (NRT + digital) will yield significantly higher rates of cessation compared to the control condition (quitline only). 2. Does 8 weeks of nicotine replacement therapy (NRT) improve initial cessation outcomes relative to no NRT. H2: Providing NRT will yield significantly higher quit rates compared to the No NRT condition. 3. Do tailored text-messages and online support during cessation improve initial cessation outcomes relative to no digital content? Are young adult vapers engaged with and satisfied with digital cessation tools? H3: Digital support will yield significantly higher quit rates compared to no digital support. H4: Higher engagement in digital content will be associated with higher cessation success rates.
Interventions
- DRUG Nicotine patch
- BEHAVIORAL Phone Counseling
- BEHAVIORAL Digital Coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 508 participants |
| Start Date | 2021-07-28 |
| Est. Completion | 2022-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04974580
The ClinicalTrials.gov registry entry for NCT04974580 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 508 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine patch is the first listed.
NCT04974580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04974580 about?
NCT04974580 is a clinical study titled "Research and Innovation to Stop E-cigarette/Vaping in Young Adults". The aim of this study is to test intervention components to help young adults quit vaping. A 2x2 factorial design will be used where all participants receive quitline-delivered behavioral phone counseling, and components to be tested are a digital intervention (with text and online cessation support...
What is the current status of trial NCT04974580?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 508 participants. The study started on 2021-07-28. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT04974580?
The interventions under investigation include: Nicotine patch (DRUG), Phone Counseling (BEHAVIORAL), Digital Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT04974580?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.